Dong Jiahuan, Qian Yufan, Zhang Guangtao, Lu Lu, Zhang Shengan, Ji Guang, Zhao Aiguang, Xu Hanchen
Institute of Digestive Diseases, Longhua Hospital, Shanghai University of Traditional Chinese Medicine, Shanghai, China.
Department of Oncology, Longhua Hospital, Shanghai University of Traditional Chinese Medicine, Shanghai, China.
Front Oncol. 2022 May 4;12:884423. doi: 10.3389/fonc.2022.884423. eCollection 2022.
Colorectal cancer (CRC) is a common cancer of the digestive system that endangers human health. Immunotherapy is widely used in the treatment of patients with cancer. Some patients with dMMR/MSI-H CRC benefit from treatments that use immune checkpoint inhibitors, but most CRC patients are not sensitive to immunotherapy. Furthermore, internal resistance and immune escape lead to a reduced immunotherapy response. Therefore, the development of an effective combination therapy to improve the response rate to immunotherapy is a goal of cancer research. Natural products are potential candidates for comprehensive cancer treatments due to their wide range of immunomodulatory effects through multifactorial underlying mechanisms. In this review, we summarize the challenges in the treatment of CRC and assess the immunomodulatory effects of natural products and their active components. Our work suggests that natural products represent potential options for combined CRC immunotherapy.
结直肠癌(CRC)是一种危害人类健康的常见消化系统癌症。免疫疗法广泛应用于癌症患者的治疗。一些错配修复缺陷(dMMR)/微卫星高度不稳定(MSI-H)的结直肠癌患者受益于使用免疫检查点抑制剂的治疗,但大多数结直肠癌患者对免疫疗法不敏感。此外,内在抗性和免疫逃逸导致免疫治疗反应降低。因此,开发一种有效的联合疗法以提高免疫治疗的反应率是癌症研究的一个目标。天然产物由于其通过多因素潜在机制具有广泛的免疫调节作用,是癌症综合治疗的潜在候选物。在本综述中,我们总结了结直肠癌治疗中的挑战,并评估了天然产物及其活性成分的免疫调节作用。我们的工作表明,天然产物是结直肠癌联合免疫治疗的潜在选择。